Showing posts with label as a potential treatment for fibrodysplasia ossificans. Show all posts
Showing posts with label as a potential treatment for fibrodysplasia ossificans. Show all posts
Monday, July 18, 2016

Palovarotene drug may prevent multiple musculoskeletal problems linked with FOP

›
We know that, Palovarotene (R-667, RO-3300074) is a highly selective retinoic acid receptor gamma (RAR-γ) agonist that is under investigat...